Would take only a decent bite to see $1.55 from here. All of...

Would take only a decent bite to see $1.55 from here. All of 100k shares available between current price and blue sky.

Really enjoying getting a better understanding of VBS. Aside from massive potential market with P1 testing about to get going, Accugen is a bit of a hidden gem. See potential for a demerger / spin-off sometime in next year or so with results coming back from partners now (and recruiting more). Accugen has potential to be a promising global tech-play quite aside from VBS core interests and could likely field good interest for an IPO on it's own esp from those who missed out on the recent raise.